Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

T2108 Update (October 1, 2015) – Stretching Oversold Conditions, Buyers

Published 10/02/2015, 12:05 AM
Updated 07/09/2023, 06:31 AM

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are occasionally posted on twitter using the #120trade hashtag. T2107 measures the percentage of stocks trading above their respective 200DMAs)

T2108 Status: 19.7%
T2107 Status: 18.8%
VIX Status: 22.6
General (Short-term) Trading Call: Bullish (upside target of 1996 on the S&P 500 before overbought conditions finally occur again. See “From the Edge of A Breakout to the Ledge of A Breakdown” for more details).
Active T2108 periods: Day #4 under 20%, Day #10 under 30%, Day #32 under 40%, Day #92 under 50%, Day #109 under 60%, Day #314 under 70%

Commentary
T2108 is itching to end this oversold period. On the eve of another job report, T2108 closed the day at 19.8% after getting as high as 22.0%. This is the fourth consecutive day of this oversold period. The S&P 500 (SPY) closed with a marginal gain and has ALMOST reversed the big one-day loss that started this week.
Chart 1
The S&P 500 (SPY) is angling for a flat week after a big sell-off on Monday caused a lot of consternation and began the current oversold period.

Along with the bounce, volatility is sinking once again. The VIX has already reversed all its gains from Monday.
Chart 2
The volatility index, the VIX, reverses quickly.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The technicals set up a relatively strong Friday, but the coming U.S. jobs report is likely to dominate the action. If the market interprets the report as good – I have NO feel for whether good news is good or bad at this juncture of rate hike anxiety – the S&P 500 (SPY) should at least finish the reversal of Monday’s loss and COULD surge to a retest of the downtrending 20DMA.

As promised, I have not added to my trades on T2108 oversold conditions. I actually sold my call options on ProShares Ultra S&P500 (NYSE:SSO) into the previous day’s rally for a nice 50% gain. I am still holding the trading shares on ProShares Short VIX Short-Term Futures (SVXY).

The iShares Nasdaq Biotechnology ETF (IBB) is the more active trade I am following. The situation is quite dynamic. Buyers FINALLY showed up this week for the first time since the “Clinton Bash.” On Tuesday, September 29th, sellers overwhelmed buyers into the close. The next day, buyers showed up in force with a small gap up and closed IBB at the previous day’s high. Today, it was the turn of buyers to reverse early action. All this action continues to happen at higher than average trading volume. If IBB can close out the week at least flat, the massive selling on record volume that brought IBB down to this level will start looking like a classic washout of panicked sellers. I post the daily and 15-minute charts to show the action.
Chart 3
The tide may be slowly turning on the iShares Nasdaq Biotechnology ETF (IBB).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Chart 4
The 15-minute chart makes more clear the basing pattern at current lows.

The intraday comeback for Apple (NASDAQ:AAPL) took the stock off recent lows. At those lows, it looked like an important follow-through of selling. AAPL continues to work downward off a failed test of resistance at its 50DMA. This downtrend is part of a larger downtrend in place since the important gap down from July earnings. Recall that bad news printed a very rare quadruple top on AAPL. While IBB is a key tell for speculative fervor and risk-taking for the market, AAPL is likely a good tell of general market health. I continue to focus on puts on AAPL as a hedge on my general bullishness. I will continue to do so until this downtrend breaks with a close and follow-through above the 50DMA.
Chart 5
Apple (AAPL) continues to struggle to exit its latest downtrend.

Daily T2108 vs the S&P 500
Chart 6

Black line: T2108 (measured on the right); Green line: S&P 500 (for comparative purposes)
Red line: T2108 Overbought (70%); Blue line: T2108 Oversold (20%)
Weekly T2108
Chart 7

Full disclosure: long SVXY shares, long SSO shares, long UVXY put options, long IBB call options, long AAPL put spread and puts

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.